Faecal Extraction System Market size was over USD 1.71 billion in 2023 and is anticipated to reach USD 2.74 billion by 2036, witnessing around 3.7% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of faecal extraction system is estimated at USD 1.76 billion. Faecal extraction system is a device used to collect stool sample of the patient in order to diagnose an infection. Various diseases, such as, inflammatory bowel disease, parasitic infection, and malabsorption syndrome are diagnosed with the help of faecal extraction systems. The growth of the market can be attributed to the increasing demand for timely diagnosis amongst patients, backed by the growing health awareness amongst people. Moreover, with the advancement in the medical technologies, doctors opt for extensive tests and diagnosis to better understand the diseases and disorders of their patients. All these factors are estimated to boost the market growth. In addition to this, the growing disposable income of people, coupled with the higher per capita health expenditure in the recent years, are anticipated to encourage the market growth. As per the data by the World Bank, the global per capita health expenditure amounted to USD 1121.796 in 2019, up from USD 874.497 in 2009.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024–2036 |
|
CAGR |
3.7% |
|
Base Year Market Size (2023) |
USD 1.71 billion |
|
Forecast Year Market Size (2036) |
USD 2.74 billion |
|
Regional Scope |
|
The market is segmented by application into parasitic infection, viral infection, bacterial indication, poor nutrient absorption, and others, out of which, the bacterial indication segment is anticipated to hold a substantial share in the global faecal extraction system market over the forecast period on account of increasing prevalence of bacterial infections, such as, typhoid and cholera. According to the data by the World Health Organization (WHO), 11 to 20 million people get sick from typhoid every year, while between 128 000-161 000 people die from it.
Our in-depth analysis of the global market includes the following segments:
|
By Assay |
|
|
By Application |
|
|
By End-User |
|
On the basis of geographical analysis, the global faecal extraction system market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in Asia Pacific region is estimated to witness noteworthy growth over the forecast period on the back of increasing prevalence of intestinal infections in the developing and underdeveloped countries, backed by the poor living conditions and sanitation.
The market in the North America region is anticipated to gain the largest market share throughout the forecast period owing to the high incidences of typhoid, cholera, and inflammatory bowel diseases, due to poor dietary habits in the population. According to the data by the Center for Disease Control and Prevention (CDC), approximately 5,700 infections of salmonella typhi, typhoid causing bacteria, occur among people in the United States each year.
April 21, 2022: American Laboratory Products Company, Ltd. (ALPCO), a specialty in vitro diagnostics company, announced a merger with GeneProof a.s. This merger will generate a global reach for ALPCO’s immunoassay testing kits, real-time PCR testing products, and automated laboratory instrumentation solutions.
October 07, 2021: Calpro AS & Ampersand Health announced the collaboration to develop CalproSmart biomarker test results incorporated into Ampersand’s digital therapeutic My IBD Care, which is a self-management and remote monitoring device for Inflammatory Bowel Disease (IBD).
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?